GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Neurizon Therapeutics NUZ.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.06

-6.25%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Neurizon Therapeutics — daily ASX:NUZ

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Neurizon Therapeutics on TradingView ↗
Market value
A$41.9m
Last close × shares
Volume
554.7k
Shares, 9 Nov 2026

About Neurizon Therapeutics

Its shares trade on ASX under the ticker NUZ.AX. It has been listed since 5 October 2001. In the fiscal year to 30 June 2024, it reported revenue of A$866,200 and a net loss of A$7.7m. At that date it held total assets of A$11.1m and shareholders' equity of A$10.2m.

PharmAust Ltd. is a pharmaceutical company, which provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2001-10-05. The principal activities of the Company are to develop its own drug discovery intellectual property, namely approximately three platforms for the treatment of different types of cancers in humans and animals, as well as providing specialized medicinal and synthetic chemistry services on a contract basis to clients. The firm's segments are Corporate and Pharmaceutical. The Pharmaceutical segment provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. The Corporate segment covers all the corporate overhead expenses. Its subsidiaries include Pitney Pharmaceuticals Pty Ltd, which is engaged in business of developing therapeutic cancer products, and Epichem Pty Ltd, which offers a range of rare and hard to find pharmaceutical impurities, degradants and metabolites of active ingredients and excipients, particularly for over-the-counter and generic drugs.

Figures and description from our data supplier, not checked against the company's own report.

More about Neurizon Therapeutics →

Latest on Neurizon Therapeutics

Our reporting

We have not reported on Neurizon Therapeutics yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Neurizon Therapeutics's ticker?

Neurizon Therapeutics trades as NUZ.AX on ASX, under ISIN AU0000357261.

What was Neurizon Therapeutics's last closing price?

0.06 on 9 Nov 2026. The figure is in AUD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.